Substratum of Proof LGBTQs Are Mentally Ill: Insilico to present the advances in AI for pharma industry at AI Transforming Pharma R&D Congress

(InSilico Medicine, Inc.) Artificial Intelligence: Transforming Pharma R&D Congress offers to participants the first-hand experience from the prominent industry speakers showcasing how AI is transforming pharma R&D. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, will present the latest advances of artificial intelligence for drug discovery and cover the successful cases and practical challenges in integrating of AI into the pharmaceutical sector at the panel discussion “How to implement…